Kinoxis Therapeutics Pty Ltd
Kinoxis Therapeutics is an early stage biotechnology company based in Australia that is working to progress the development of a range of novel therapeutic compounds for the treatment of substance use disorders and other CNS conditions. The company has licensed these compounds from the University of ...
View Top Employees for Kinoxis Therapeutics Pty Ltd
Website | kinoxistherapeutics.com | |
Industry | Biotechnology | |
Location | Melbourne, Victoria, Australia | |
Employees | 7 | |
Founded | 2017 |
Funding | 7,697,765 USD |
Website | kinoxistherapeutics.com | |
Industry | Biotechnology | |
Location | Melbourne, Victoria, Australia | |
Employees | 7 | |
Founded | 2017 | |
linkedin.com/company/kinoxis-therapeutics-pty-ltd | ||
Funding | 7,697,765 USD |
Kinoxis Therapeutics Pty Ltd Questions
Where are Kinoxis Therapeutics Pty Ltd's headquarters?
Kinoxis Therapeutics Pty Ltd's headquarters are in
What is Kinoxis Therapeutics Pty Ltd's official website?
Kinoxis Therapeutics Pty Ltd's website is kinoxistherapeutics.com
How many employees are working in Kinoxis Therapeutics Pty Ltd right now?
Kinoxis Therapeutics Pty Ltd has
7 employees.
View the Email and Phone Numbers for all 7 working at Kinoxis Therapeutics Pty Ltd.
What is Kinoxis Therapeutics Pty Ltd's industry?
Kinoxis Therapeutics Pty Ltd's industry is
Biotechnology
What are Kinoxis Therapeutics Pty Ltd's categories?
Kinoxis Therapeutics Pty Ltd's categories are Biotechnology, Therapeutics
What is Kinoxis Therapeutics Pty Ltd's location?
Kinoxis Therapeutics Pty Ltd's location is
Melbourne, Victoria, Australia
When was Kinoxis Therapeutics Pty Ltd's founded?
Kinoxis Therapeutics Pty Ltd's founding year is 2017
What is Kinoxis Therapeutics Pty Ltd's funding?
Kinoxis Therapeutics Pty Ltd's funding is 7,697,765 USD
What is Kinoxis Therapeutics Pty Ltd's current status?
Kinoxis Therapeutics Pty Ltd's current status is operating
Top Kinoxis Therapeutics Pty Ltd Employees
Drug Development Associate
luong_r@subway.com
Co Founder And Chief Scientific Officer
Vice President, Drug Development
sharon.hanegraaf@acrux.com.au